Is It an Adolescent Phase, or Something More Serious?

As part of our daughter's treatment for MDD, our doctor prescribed Lexapro, which is approved for use in adolescents aged 12-17 years.

Caring for an Adolescent With Depression

Is Lexapro approved for depression in adolescents?

Lexapro is approved for the acute and maintenance treatment of Major Depressive Disorder (MDD) in adolescents aged 12-17. Lexapro is the second antidepressant to be approved for the treatment...more

Is depression common among adolescents?

Yes. Approximately 2 million U.S. adolescents aged 12 to 17 have suffered a serious bout of depression in the past year...more

Lexapro Side Effects

Patients may experience side effects when taking an antidepressant medication.

view side effects

Why Take Lexapro?

Lexapro is approved as a safe and effective treatment for MDD in adults and adolescents and for GAD in adults.

Learn more about Lexapro

Lexapro for Depression in Adolescents (aged 12-17)

Lexapro is the second medication approved for the treatment of major depressive disorder in adolescents 12-17 years of age.

Learn About Depression in Adolescents

Websites About Depression in Adolescents

A variety of websites that can help put you in touch with self-help, advocacy, and support groups whose members share your issues and concerns.

View Recommended Websites

© 2012 Forest Laboratories, Inc.
41-1018520 07/10

If you have any questions, discuss them with your doctor or healthcare professional.  For additional information about Lexapro, call the Forest Medical Information and Communication Department toll-free at 800-678-1605, ext. 66297.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.People depicted in images are models. Images are used for illustrative purposes only.

Close

You are now leaving the Lexapro Website. Links to other websites are provided as a service to you. Forest Laboratories accepts no responsibility for the content of other Websites. Would you like to continue?

YesNo